Researchers applied a SNP heritability model called LDAK to genetic data for a range of human traits, uncovering relatively high levels of variance explained by SNPs.
The agreement gives Ventana access to results from a collaboration and licensing agreement that Transgenomic made separately with the University of Melbourne.
A clear unmet clinical need coupled with the persuasive study data suggests that it shouldn't be long before this type of testing is made available clinically.
The deal covers four of Transgenomic's liquid biopsy cancer assays, which detect actionable mutations associated with sensitivity or resistance to therapy.
The Doherty Centre for Applied Microbial Genomics will use genomics to identify and track outbreaks of infectious disease, including antibiotic-resistant bacteria.
